Folic acid and multivitamin supplements associated with reduced autism risk

By |2018-01-08T09:06:52-08:00January 8th, 2018|Brief Bulletins from the Field, We Know Psychiatry|

Taking folic acid and/or multivitamin supplements preceding and during pregnancy is associated with a lower risk of offspring developing autism spectrum disorder (ASD), an observational epidemiologic study published Jan. 3 showed. The findings could have important public health implications, reported Stephen Z. Levine, PhD, and his associates. The case-cohort study included [...]

New Summaries of Anxiety Disorders

By |2017-12-28T06:59:57-08:00December 28th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Attention Bias, Threat/Anxiety Symptoms Linked A recent study indicates associations between threat bias and pediatric anxiety symptoms, and suggests that vigilance to external threats manifests more prominently in symptoms of social anxiety and school phobia, regardless of age and gender. These findings point to the role of attention bias to [...]

Plasticity and Its Association With Working Memory in Patients With Alzheimer Disease

By |2021-11-11T17:05:32-08:00October 28th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Is dorsolateral prefrontal cortex plasticity impaired in Alzheimer disease? Yes, according to researchers writing in JAMA Psychiatry. Dorsolateral prefrontal cortex plasticity is impaired in Alzheimer disease and is associated with impaired working memory. Findings:  In this cross-sectional study of 32 participants with early Alzheimer disease and 16 healthy control participants, significant [...]

Association of Lithium in Drinking Water With the Incidence of Dementia

By |2021-11-11T17:06:32-08:00August 25th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Original Investigation Association of Lithium in Drinking Water With the Incidence of Dementia Lars Vedel Kessing,  Thomas Alexander Gerds,  Nikoline Nygård Knudsen, Lisbeth Flindt Jørgensen, Søren Munch Kristiansen, Denitza Voutchkova, Vibeke Ernstsen, Jörg Schullehner, Birgitte Hansen, Per Kragh Andersen, Annette Kjær Ersbøll Question  Is a higher lithium level in drinking water associated with a decreased incidence of dementia? Findings  In this Danish nationwide, population-based, [...]

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia

By |2021-11-11T17:07:39-08:00June 19th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Original Investigation By Jari Tiihonen, MD,  Ellenor Mittendorfer-Rutz, Maila Majak; et al   Key Points Question  Are there any clinically meaningful differences between specific antipsychotic medications or routes of administration regarding the risk of psychiatric rehospitalization or other treatment failure? Findings  This database study of a nationwide cohort of patients using within-individual analysis to eliminate [...]

Mental Anguish of Britain’s Prince Harry Focuses on Grief and Depression

By |2021-11-11T17:13:10-08:00April 19th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

The Achilles Heel of psychiatry has always been the public's distrust of what defines a mental disorder and whether it can be treated effectively. Oftentimes, not until a trusted public person speaks up about his or her battle with a mental disorder does the public, in turn, accept the disease [...]

Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder A Randomized Clinical Trial

By |2016-08-27T16:42:44-07:00August 27th, 2016|We Know Psychiatry|

By Evdokia Anagnostou, MD1; Michael G. Aman, PhD; Benjamin L. Handen, PhD, et al. ABSTRACT Importance Atypical antipsychotic medications are indicated for the treatment of irritability and agitation symptoms in children with autism spectrum disorder (ASD). Unfortunately, these medications are associated with weight gain and metabolic complications that are especially [...]

Atypical Antipsychotic-Induced Weight Gain in Children and Adolescents: Sometimes Less Is More

By |2016-08-27T16:35:02-07:00August 27th, 2016|We Know Psychiatry|

EDITORIAL By Christopher J. McDougle, MD In this issue of JAMA Psychiatry, Anagnostou et al1 present results of a double-blind, placebo-controlled study of metformin for weight management in children and adolescents with autism spectrum disorder (ASD) treated with an atypical antipsychotic medication. Metformin was significantly more efficacious than the placebo [...]

Self-harm, Unintentional Injury, and Suicide in Bipolar Disorder During Maintenance Mood Stabilizer Treatment

By |2016-05-15T01:19:08-07:00May 15th, 2016|We Know Psychiatry|

A UK Population-Based Electronic Health Records Study Joseph F. Hayes, MSc, MBChB; Alexandra Pitman, PhD; Louise Marston, PhD; Kate Walters, PhD; John R. Geddes, MD; Michael King, PhD; David P. J. Osborn, PhD (JAMA Psychiatry. Published online May 11, 2016. doi:10.1001/jamapsychiatry.2016.0432) ABSTRACT  Importance  Self-harm is a prominent cause of morbidity in patients with bipolar disease and is strongly associated with suicide. There is evolving [...]

Latest Psychiatric News: Menopause & Depression, World Mental Health Surveys, and Early Intervention

By |2016-02-04T16:07:57-08:00February 4th, 2016|We Know Psychiatry|

Early Intervention for Psychotic Disorders: Building Population Health Systems This Viewpoint proposes a conceptual framework for population health systems that would enable early intervention services for patients with new-onset psychotic disorders. Treatment works; the earlier, the better. The intuition that, if applied early in the course of illness, available treatments for [...]

Title

Go to Top